Receptor-Ck regulates the expression of cyclin-dependent kinase inhibitors (p16; p27)

被引：0
|
作者：
D. Kaul
M. Kaur
机构：
[1] Postgraduate Institute of Medical Education and Research,Molecular Biology Unit, Department of Experimental Medicine and Biotechnology
来源：
Molecular and Cellular Biochemistry | 1999年 / 200卷
关键词：
mevalonate pathway; CDK inhibitors; Receptor-C; expression; TPA; HL-60 cell line;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The present study was addressed to understand the interrelationship between Receptor-Ck induction-activation coupling; isoprenoids (derived from mevalonate pathway) and cyclin-dependent kinase inhibitors. The results reported here unambiguously reveal that isoprenoids regulate the expression of genes coding for CDK inhibited p16 and p27. Further, Receptor-Ck dependent signalling, known to control the mevalonate pathway, had a direct effect upon the p27 gene expression. Based upon these studies coupled with our earlier findings we propose that Receptor-Ck has an important role in the regulation of cell cycle machinery.
引用
收藏
页码：183 / 186
页数：3
相关论文
共 50 条
  • [31] BOTH P16 AND P21 FAMILIES OF CYCLIN-DEPENDENT KINASE (CDK) INHIBITORS BLOCK THE PHOSPHORYLATION OF CYCLIN-DEPENDENT KINASES BY THE CDK-ACTIVATING KINASE
    APRELIKOVA, O
    XIONG, Y
    LIU, ET
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (31) : 18195 - 18197
  • [32] Tissue Microarray Analysis of Cyclin-Dependent Kinase Inhibitors p21 and p16 in Fuchs Dystrophy
    Matthaei, Mario
    Lackner, Eva-Maria
    Meng, Huan
    Hicks, Jessica L.
    Meeker, Alan K.
    Eberhart, Charles G.
    Jun, Albert S.
    CORNEA, 2013, 32 (04) : 473 - 478
  • [33] Regulation and role of p21 and p27 cyclin-dependent kinase inhibitors during hepatocyte differentiation and growth
    Ilyin, GP
    Glaise, D
    Gilot, D
    Baffet, G
    Guguen-Guillouzo, C
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2003, 285 (01): : G115 - G127
  • [34] Differential expression of p27(Kip1), p21(Cip1) and p16(INK) cyclin dependent kinase inhibitors in vascular disease
    Tanner, FC
    Yang, ZY
    Gordon, D
    Nabel, GJ
    Nabel, EG
    CIRCULATION, 1997, 96 (08) : 244 - 244
  • [35] Evaluation of Rb gene and cyclin-dependent kinase inhibitors p21 and p27 in pleomorphic xanthoastrocytoma.
    Rushing, E
    Quezado, M
    Evangelista, R
    Santi, M
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2005, 64 (05): : 439 - 439
  • [36] The cyclin-dependent kinase inhibitors p57 and p27 regulate neuronal migration in the developing mouse neocortex
    Itoh, Yasuhiro
    Masuyama, Norihisa
    Nakayama, Keiko
    Nakayama, Keiichi I.
    Gotoh, Yukiko
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (01) : 390 - 396
  • [37] The tuberous sclerosis genes and regulation of the cyclin-dependent kinase inhibitor p27
    Rosner, Margit
    Freilinger, Angelika
    Hengstschaeger, Markus
    MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2006, 613 (01) : 10 - 16
  • [38] Characterization of the murine cyclin-dependent kinase inhibitor gene p27(Kip).
    Kwon, TK
    Nagel, J
    Buchholz, M
    Nordin, A
    FASEB JOURNAL, 1996, 10 (06): : 2608 - 2608
  • [39] Expression of cyclin dependent kinase inhibitors, p21 and p27, during cardiac hypertrophy in rats
    Li, JM
    Brooks, G
    CIRCULATION, 1996, 94 (08) : 3221 - 3221
  • [40] EXPRESSION OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P16 DURING THE ONGOING CELL-CYCLE
    SOUCEK, T
    PUSCH, O
    HENGSTSCHLAGEROTTNAD, E
    WAWRA, E
    BERNASCHEK, G
    HENGSTSCHLAGER, M
    FEBS LETTERS, 1995, 373 (02) : 164 - 169
12345